Thrivent Financial For Lutherans Charles River Laboratories International, Inc. Transaction History
Thrivent Financial For Lutherans
- $51.6 Billion
- Q4 2024
A detailed history of Thrivent Financial For Lutherans transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 5,423 shares of CRL stock, worth $949,675. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,423
Previous 332,662
98.37%
Holding current value
$949,675
Previous $65.5 Million
98.47%
% of portfolio
0.0%
Previous 0.12%
Shares
30 transactions
Others Institutions Holding CRL
# of Institutions
710Shares Held
53.9MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$1.08 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$891 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$714 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$382 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$317 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.91B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...